Investing Profile

Lionel Carnot

InvestorVC
Partner at Earlybird Venture Capital
Photo of Lionel Carnot, Partner at Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Accenture Network
268 CONNECTIONS
Booz Allen Hamilton Network
53 CONNECTIONS
Earlybird Venture Capital Network
50 CONNECTIONS
Eli Lilly and Company Network
23 CONNECTIONS
University of Geneva Network
13 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
€350m
CompanyStageDateRound SizeTotal Raised
Oculis
Series CMay 2021$57M
Series BJan 2018$21M
$190M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Rob Hopfner (Pivotal bioVenture Partners), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Priothera
Series AOct 2020$35M
$35M
Co-investors: Marten Steen (HealthCap)
Merus
Series CApr 2015$79M
Series BOct 2013$42M
Series BJan 2010$30M
$150M
Co-investors: John de Koning (LSP), Florent Gros (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)
R&D Tools, Ophtalmology, Dermatology
Sales & Marketing Rhone-Poulenc RorerPresent
Senior Consultant AccenturePresent
Product Manager Eli Lilly and CompanyPresent
Senior Associate Booz Allen HamiltonPresent
Principal Oracle PartnersPresent
Associate The Pritzker OrganizationPresent
Member Board of Directors Reliant PharmaceuticalsPresent
Member Board of Directors Pathway DiagnosticsPresent
Member Board of Directors BioSeek, Inc.Present
Managing Director Bay City Capital LLCPresent
Member Board of Directors Merus N.V.Present
Member Board of Directors Madrigal PharmaceuticalsPresent
Member Board of Directors Interleukin GeneticsPresent
Member Board of Directors NABsysPresent
Member Board of Directors iQone Healthcare SwitzerlandPresent
Board Member INNOVOPresent
Board Member OculisPresent
Board Member iSTAR MedicalPresent
Partner Earlybird Venture CapitalPresent
University of Geneva MSc Molecular Biology